Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy

Circulation

Volumn 89, Issue 6, 1994, Pages 2582-2589

  Why, Howard J F ^a   Meany, Brendan T ^a   Richardson, Peter J ^a   Olsen, Eckhard G J ^b   Bowles, Neil E ^c   Cunningham, Louise ^c   Freeke, Colette A ^c   Archard, Leonard C ^c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

biopsy; cardiomyopathy; myocarditis; prognosis; viruses

Indexed keywords

VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENTEROVIRUS; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE BIOPSY; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDITIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; VIRUS DETECTION;

EID: 0028232695     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.89.6.2582     Document Type: Article

References (50)

1. Montague TJ, Lopaaschuk GD, Davies NJ. Viral heart disease. Chest. 1990;98:190-199.
2. Peters NS, Poole-Wilson PA. Myocarditis: continuing clinical and pathologic confusion. Am Heart J. 1991;121:942-947.
3. Dilated cardiomyopathy and enteroviruses. Lancet. 1990;336: 971-973. Editorial.
4. Lie JT. Myocarditis and endomyocardial biopsy in unexplained heart failure: a diagnosis in search of a disease. Ann Intern Med. 1988;109:525-528.
5. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J. 1980;44:672-673.
6. Cambridge G, MacArthur CGC, Waterson AP, Goodwin JF, Oakley CM. Antibodies to coxsackie B viruses in primary congestive cardiomyopathy. Br Heart J. 1979;41:692-696.
7. Muir P, Tizley AJ, English TAH, Nicholson F, Signey M, Banatvala JE. Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet. 1989;1:804-807.
8. Grist NR, Bell EJ, Assaad F. Enteroviruses in human disease. In: Melnick JL, ed. Progress in Medical Virology 24. Basel, Switzerland: Karger; 1978:114-157.
9. Morgan-Capner P, Richardson PJ, McSorley C, Daly K, Pattison JR. Virus investigations in heart muscle disease. In: Bolte H-D, ed. Viral Heart Disease. Berlin, Germany: Springer-Verlag; 1984: 99-115.
10. Kandolf R, Hofschneider PH. Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A. 1985;82:4818-4822.
11. Bowles NE, Richardson PJ, Olsen EGJ, Archard LC. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet. 1986;1:1120-1123.
12. Archard LC, Bowles NE, Olsen EGJ, Richardson PJ. Detection of persistent coxsackie B virus RNA in dilated cardiomyopathy and myocarditis. Eur Heart J. 1987;8(suppl J):437-440.
13. Bowles NE, Rose ML, Taylor P, Banner NR, Morgan-Capner P, Cunningham L, Archard LC, Yacoub MH. End-stage dilated cardiomyopathy: persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation. 1989;80:1128-1136.
14. Sandier H, Dodge HT. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J. 1968;75:325-334.
15. Richardson PJ. King's endomyocardial bioptome. Lancet. 1974;1: 660-661.
16. Richardson PJ. Endomyocardial biopsy technique and evaluation of a new disposable forceps and catheter sheath system. In: Bolte H-D, ed. Viral Heart Disease. Berlin, Germany: Springer Verlag; 1984:173-176.
17. Olsen EGJ. Diagnostic value of the endomyocardial bioptome. Lancet. 1984;1:658-660.
18. Olsen EGJ. Histologic aspects of viral myocarditis and its diagnostic criteria. In: Sekiguchi M, Olsen EJG, Goodwin JF, eds. Myocarditis and Related Disorders. Berlin, Germany: Springer Verlag; 1985:130-132.
19. Olsen EJG. Pathology of cardiomyopathies: a critical analysis. Am Heart J. 1979;98:385-392.
20. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Olsen EGJ, Schoen FJ. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol. 1986;1:3-14.
21. Kaczmarek B, Calabretta B, Baserga R. Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes. Proc Natl Acad Sci USA. 1985;82:5375-5379.
22. Francis SE, Duff GW. 7B6, a ubiquitous mRNA: with significant homology to L41 human ribosomal protein RNA. Nucleic Acids Res. 1993;21:2944.
23. Richardson P, Why H. Clinical spectrum of viral heart disease. In: Banatvala JE, ed. Viral Infections of the Heart, London, UK: Edward Arnold; 1993:59-82.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
25. Popma JJ, Cigarroa RG, Buja LM. Diagnostic and prognostic utility of right-sided catheterization and endomyocardial biopsy in idiopathic dilated cardiomyopathy. Am J Cardiol. 1989;63:955-958.
26. Dec GW, Fallon JT, Southern JF, Palacios IF. Relation between histological findings on early repeat right ventricular biopsy and ventricular function in patients with myocarditis. Br Heart J. 1988; 60:332-337.
27. Jiullière Y, Danchin N, Briancon S, Khalife K, Ethévenot G, Balaud A, Gilgenkrantz JM, Pernot C, Cherrier F. Dilated cardiomyopathy: long-term follow-up and predictors of survival. Int J Cardiol. 1988;21:269-277.
28. Diaz RA, Obasohan A, Oakley CM. Prediction of outcome in dilated cardiomyopathy. Br Heart J. 1987;58:393-399.
29. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV, Factors influencing the one-year mortality of dilated cardiomyopathy. Am J CardioL 1984;54:147-152.
30. Quigley PJ, Richardson PJ, Meaney BT, Olsen EGJ, Monaghan MJ, Jackson G, Jewitt DE. Long-term follow-up of acute myocarditis: correlation of ventricular function and outcome. Eur Heart J. 1987;8(suppl J):39-42.
31. Latham RD, Mulrow JP, Virmani R, Robinowitz M, Moody JM. Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisolone therapy. Am Heart J. 1989;117:876-882.
32. Komajda M, Jais JP, Reeves F, Goldfarb B, Bouhour JB, Juillieres Y, Lanfranchi J, Peychelon P, Geslin P, Carrie D, Grosgogeat Y. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J. 1990;11:824-831.
33. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981;47:525-531.
34. Baandrup U, Florio RA, Rehahn M, Richardson PJ, Olsen EGJ. Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. Br Heart J. 1981;45:487-493.
35. Levi G, Scalvini S, Volterrani M, Marangoni S, Arosio G, Quadri A. Coxsackie virus heart disease: 15 years after. Eur Heart J. 1987;8(suppl J):1303-1307.
36. Remes J, Helin M, Vaino P, Rautio P. Clinical outcome and left ventricular function 23 years after acute Coxsackie virus myopericarditis. Eur Heart J. 1990;11:182-188.
37. Archard LC, Cunningham L, Freeke CA, Morgan-Capner P, Why HJF, Richardson PJ. Correlation of coxsackie B virus-specific IgM with the presence of enterovirus RNA sequences in endomyocardial biopsy samples from cases of inflammatory or dilated heart muscle disease. Eur Heart J. 1991;12(suppl):229. Abstract.
38. Brigden W, Robinson J. Alcoholic heart muscle disease. Br Med J. 1964;2:1283-1289.
39. Regan T. Alcoholic cardiomyopathy. Prog Cardiovasc Dis. 1984;17: 141-152.
40. Richardson PJ, Wodak AD, Atkinson L, Saunders JB, Jewitt DE. Relation between alcohol intake, myocardial enzyme activity, and myocardial function in dilated cardiomyopathy: evidence for the concept of alcohol induced heart muscle disease. Br Heart J. 1986; 56:165-170.
41. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Kunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration cooperative study. N Engl J Med. 1986;314: 1547-1552.
42. Kannel WB, Plehn JF, Cupples LA. Cardiac failure and sudden death in the Framingham study. Am Heart J. 1988;115:869-875.
43. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV, Abelmann WH, Harlan WR. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am Heart J. 1992;69:1458-1466.
44. Tamburro P, Wilber D. Sudden death in idiopathic dilated cardiomyopathy. Am Heart J. 1992;124:1035-1045.
45. Lohr JM, Oldstone MB. Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes. Lancet. 1990;336: 644-648.
46. Schwaiger A, Umlauft F, Weyrer K, Larcher C, Lyons J, Mühlberger V, Dietze O, Grünewald K. Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction. Am Heart J. 1993;126:406-410.
47. Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, Liew CC. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation. 1990; 82:8-16.
48. Weiss LM, Movahed LA, Billingham ME, Cleary ML. Detection of coxsackievirus B3 in myocardial tissues by the polymerase chain reaction. Am J Pathol. 1991;138:497-503.
49. Cunningham L, Bowles NE, Lane RJM, Dubowitz V, Archard LC. Persistence of enterovirus RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J Gen Virol. 1990;71:1399-1402.
50. Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR. Selective gene expression in the failing human heart. Circulation. 1991;83:1866-1872.